These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 38328844)

  • 21. Effects of Toll-like receptor 7 and Toll-like receptor 9 signaling stimulators and inhibitors on chronic lymphocytic leukemia cells ex vivo and their interactions with cladribine.
    Wolska A; Cebula-Obrzut B; Smolewski P; Robak T
    Leuk Lymphoma; 2013 Jun; 54(6):1268-78. PubMed ID: 23078646
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Soluble interleukin-2 receptor, soluble CD8 and soluble intercellular adhesion molecule-1 levels in hematologic malignancies.
    Srivastava MD; Srivastava A; Srivastava BI
    Leuk Lymphoma; 1994 Jan; 12(3-4):241-51. PubMed ID: 7909467
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cytokine modulation of nuclear factor-kappaB activity in B-chronic lymphocytic leukemia.
    Zaninoni A; Imperiali FG; Pasquini C; Zanella A; Barcellini W
    Exp Hematol; 2003 Mar; 31(3):185-90. PubMed ID: 12644014
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fibromodulin, an extracellular matrix protein: characterization of its unique gene and protein expression in B-cell chronic lymphocytic leukemia and mantle cell lymphoma.
    Mikaelsson E; Danesh-Manesh AH; Lüppert A; Jeddi-Tehrani M; Rezvany MR; Sharifian RA; Safaie R; Roohi A; Osterborg A; Shokri F; Mellstedt H; Rabbani H
    Blood; 2005 Jun; 105(12):4828-35. PubMed ID: 15741214
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Linking SLAMF1 to autophagy and sensitivity to therapy in chronic lymphocytic leukemia.
    Bologna C; Deaglio S
    Mol Cell Oncol; 2018; 5(3):e1143077. PubMed ID: 30250877
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modulation of IL-4 level by fludarabine and its relation to apoptosis in chronic B-cell lymphocytic leukemia.
    Shamaa LA; Hussein Ael-S; Balbaa OA; Farahat NM; Ali MA
    Egypt J Immunol; 2008; 15(1):181-92. PubMed ID: 20306682
    [TBL] [Abstract][Full Text] [Related]  

  • 27. On CK2 regulation of chronic lymphocytic leukemia cell viability.
    Martins LR; Lúcio P; Silva MC; Gameiro P; Silva MG; Barata JT
    Mol Cell Biochem; 2011 Oct; 356(1-2):51-5. PubMed ID: 21750986
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dendritic cell-based immunogens for B-cell chronic lymphocytic leukemia.
    Allgeier T; Garhammer S; Nössner E; Wahl U; Kronenberger K; Dreyling M; Hallek M; Mocikat R
    Cancer Lett; 2007 Jan; 245(1-2):275-83. PubMed ID: 16516377
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression Analysis of Fyn and Bat3 Signal Transduction Molecules in Patients with Chronic Lymphocytic Leukemia.
    Hosseini-Valiki F; Taghiloo S; Tavakolian G; Amjadi O; Tehrani M; Hedayatizadeh-Omran A; Alizadeh-Navaei R; Zaboli E; Shekarriz R; Asgarian-Omran H
    Asian Pac J Cancer Prev; 2020 Sep; 21(9):2615-2621. PubMed ID: 32986360
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeted inhibition of eIF4A suppresses B-cell receptor-induced translation and expression of MYC and MCL1 in chronic lymphocytic leukemia cells.
    Wilmore S; Rogers-Broadway KR; Taylor J; Lemm E; Fell R; Stevenson FK; Forconi F; Steele AJ; Coldwell M; Packham G; Yeomans A
    Cell Mol Life Sci; 2021 Sep; 78(17-18):6337-6349. PubMed ID: 34398253
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aberrant expression of TRAIL in B chronic lymphocytic leukemia (B-CLL) cells.
    Secchiero P; Tiribelli M; Barbarotto E; Celeghini C; Michelutti A; Masolini P; Fanin R; Zauli G
    J Cell Physiol; 2005 Nov; 205(2):246-52. PubMed ID: 15887227
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cytokine gene expression in B-cell chronic lymphocytic leukemia: evidence of constitutive interleukin-8 (IL-8) mRNA expression and secretion of biologically active IL-8 protein.
    di Celle PF; Carbone A; Marchis D; Zhou D; Sozzani S; Zupo S; Pini M; Mantovani A; Foa R
    Blood; 1994 Jul; 84(1):220-8. PubMed ID: 7517209
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CD79b expression in B cell chronic lymphocytic leukemia: its implication for minimal residual disease detection.
    Garcia Vela J; Delgado I; Benito L; Monteserin M; Garcia Alonso L; Somolinos N; Andreu M; Oña F
    Leukemia; 1999 Oct; 13(10):1501-5. PubMed ID: 10516749
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Type 4 cyclic adenosine monophosphate phosphodiesterase as a therapeutic target in chronic lymphocytic leukemia.
    Kim DH; Lerner A
    Blood; 1998 Oct; 92(7):2484-94. PubMed ID: 9746789
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nurselike cells express BAFF and APRIL, which can promote survival of chronic lymphocytic leukemia cells via a paracrine pathway distinct from that of SDF-1alpha.
    Nishio M; Endo T; Tsukada N; Ohata J; Kitada S; Reed JC; Zvaifler NJ; Kipps TJ
    Blood; 2005 Aug; 106(3):1012-20. PubMed ID: 15860672
    [TBL] [Abstract][Full Text] [Related]  

  • 36. SENP2 exerts an anti‑tumor effect on chronic lymphocytic leukemia cells through the inhibition of the Notch and NF‑κB signaling pathways.
    Chen XL; Wang SF; Liang XT; Liang HX; Wang TT; Wu SQ; Qiu ZJ; Zhan R; Xu ZS
    Int J Oncol; 2019 Feb; 54(2):455-466. PubMed ID: 30431078
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Non-malignant leukocytes delay spontaneous B-CLL cell apoptosis.
    Gamberale R; Geffner J; Arrosagaray G; Scolnik M; Salamone G; Trevani A; Vermeulen M; Giordano M
    Leukemia; 2001 Dec; 15(12):1860-7. PubMed ID: 11753606
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Widespread B29 (CD79b) gene defects and loss of expression in chronic lymphocytic leukemia.
    Thompson AA; Do HN; Saxon A; Wall R
    Leuk Lymphoma; 1999 Feb; 32(5-6):561-9. PubMed ID: 10048429
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differences in constitutive and activation-induced expression of CD69 and CD95 between normal and chronic lymphocytic leukemia B cells.
    De Fanis U; Romano C; Dalla Mora L; Sellitto A; Guastafierro S; Tirelli A; Bresciano E; Giunta R; Lucivero G
    Oncol Rep; 2003; 10(3):653-8. PubMed ID: 12684639
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Silencing of HDAC6 as a therapeutic target in chronic lymphocytic leukemia.
    Maharaj K; Powers JJ; Achille A; Deng S; Fonseca R; Pabon-Saldana M; Quayle SN; Jones SS; Villagra A; Sotomayor EM; Sahakian E; Pinilla-Ibarz J
    Blood Adv; 2018 Nov; 2(21):3012-3024. PubMed ID: 30425065
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.